as on February 14, 2026 at 3:48 am IST
Day's High
1.66%
Upside
52 Week's Low
52 Week's High
23.83%
Downside
14.55%
Upside
Check Puretech Health Plc - Adr market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$422.0M
EPS (TTM)
-3.8
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.61%
PE Ratio (TTM)
10.27
Industry PE ratio
-3.5951014492753623
PEG Ratio
0EBITDA
-115.7M
Revenue (TTM)
6.4M
Profit Margin
792.96%
Return On Equity TTM
9.44%
Track how Puretech Health Plc - Adr P/E has moved over time to understand its valuation trends.
Puretech Health Plc - Adr in the last 5 years
Lowest (-153.60x)
June 30, 2023
Industry (-3.60x)
February 16, 2026
Today (10.27x)
February 16, 2026
Highest (87.89x)
September 30, 2025
Today’s Price to Earnings Ratio: 10.27x
Compare market cap, revenue, PE, and other key metrics of Puretech Health Plc - Adr with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $422.0M | NA | 10.27 | 792.96% | |
| BUY | $126.0B | 133.73% | 32.06 | 32.94% | |
| NA | $38.3B | NA | 665.52 | 1.38% | |
| BUY | $41.7B | 104.41% | 134.94 | 8.45% | |
| BUY | $84.9B | 67.08% | 19.38 | 31.41% |
Based on 6 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 6 analysts, 83.33% of analysts recommend a 'BUY' rating for Puretech Health Plc - Adr. Average target price of $46
Get share price movements and forecasts by analysts on Puretech Health Plc - Adr.
What analysts predicted
62.04%UPSIDE
Target Price
$46
Current Price
$17.46
Analyzed by
6 Analysts
Target
$46.00
Puretech Health Plc - Adr target price $46, a slight upside of 62.04% compared to current price of $17.46. According to 6 analysts rating.
Search interest for Puretech Health Plc - Adr Stock has decreased by -8% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 03 November
Mon, 07:37 PM
-Gallop Oncology reports promising results for LYT-200 in AML trial, showing over 30% complete response rate.
Tue, 02:41 AM
-PureTech announces LYT-200 data presentation at ASH meeting, highlighting ongoing trial's clinical activity in AML.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 49.9% return, outperforming this stock by 57.8%
Against Peers
![]()
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.0% return, outperforming this stock by 86.9%
Price Dip
![]()
In the last 3 years, PRTC stock has moved down by -39.9%
Profit Down
![]()
Netprofit is down for the last 2 quarters, 95.28M → -44.60M (in $), with an average decrease of 146.8% per quarter
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 4.02M → 1.85M (in $), with an average decrease of 54.0% per quarter
| Organisation | Puretech Health Plc - Adr |
| Headquarters | 6 Tide Street, Boston, MA, United States, 02210 |
| Industry | Health Technology |
| CEO | Mr. Robert Lyne J.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Eric Elenko Ph.D. | Co-Founder & President |
Ms. Allison Mead Talbot | Senior VP of Communications & Head of Investor Relations |
Mr. Charles Sherwood III, J.D., Ph.D. | General Counsel & Company Secretary |
Mr. Spencer Ball | Executive Vice President of Human Resources |
Ms. Daphne Zohar | Founder |
Dr. Robert S. Langer Jr., Ph.D., ScD | Co-Founder & Non-Executive Director |
Mr. Robert Lyne J.D. | CEO & Director |
Dr. David R. Elmaleh Ph.D. | Co-Founder & Senior Advisor |
Ms. Lauren A. White M.B.A. | Chief Financial Officer |
Mr. Michael Inbar CPA, M.B.A. | Chief Accounting Officer |
Puretech Health Plc - Adr share price today is $17.46 as on at the close of the market. Puretech Health Plc - Adr share today touched a day high of $17.75 and a low of $17.46.
Puretech Health Plc - Adr share touched a 52 week high of $20 on and a 52 week low of $13.3 on . Puretech Health Plc - Adr stock price today i.e. is closed at $17.46,which is 12.70% down from its 52 week high and 31.28% up from its 52 week low.
Puretech Health Plc - Adr market capitalisation is $0.00T as on .
Indian investors can start investing in Puretech Health Plc - Adr (PRTC) shares with as little as ₹90.626 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹906.26 in Puretech Health Plc - Adr stock (as per the Rupee-Dollar exchange rate as on ).
Based on Puretech Health Plc - Adr share’s latest price of $17.46 as on February 13, 2026 at 10:18 pm IST, you will get 0.5727 shares of Puretech Health Plc - Adr. Learn more about
fractional shares .